Riskpilot← Back to searchSign inGet full accessPharmacare Nova Oy
OYDissolvedY-tunnus 1051651-0Keskikankaantie 29Manufacture of soap and detergents, cleaning and polishing preparations · NACE 2041Est. 19961 employeeswww.finntack.com
Revenue 2023
EUR 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2023
EUR 0
-100% vs 2020
| Revenue | EUR 0 | — |
| EBITDA | EUR 0 | — |
| Net profit | EUR 0 | -100% |
| Total assets | EUR 0 | -100% |
| Equity | EUR 0 | -100% |
| Employees | 1 | — |
Legal name
Pharmacare Nova Oy
Y-tunnus number
1051651-0
Legal form
Osakeyhtiö
NACE code
2041 · Manufacture of soap and detergents, cleaning and polishing preparations
Founded
29. toukokuuta 1996
Share capital
EUR 8 580
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on teknokemiallisten tuotteiden valmistus-, myynti-, vienti- ja tuontitoiminta. Hevostarvikkeiden osto-, myynti-, vienti- ja tuontitoiminta. Hevosalan julkaisutoiminta ja kauppa. Yhtiö voi hankkia omistukseensa ja myydä kiinteätä omaisuutta ja arvopapereita.
Address
Keskikankaantie 29
Phone
+358438251135
Email
info@finntack.com
Website
www.finntack.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2023 |
|---|---|---|---|
| Revenue | 171 | 1 917 | 0 |
| Staff expenses | −58 | −204 | −0 |
| EBITDA | −36 | 420 | 0 |
| Depreciation & amort. | −16 | −87 | −0 |
| EBIT | −52 | 333 | 0 |
| Net financials | −4 | −4 | 0 |
| Profit before tax | −116 | 429 | 0 |
| Tax | 1 | 66 | −0 |
| Net profit | 2 | 163 | 0 |
| Item | 2019 | 2020 | 2023 |
|---|---|---|---|
| Total assets | 283 | 1 151 | 0 |
| Equity | 258 | 422 | 0 |
| Long-term debt | — | — | 0 |
| Short-term debt | 25 | 729 | 0 |
| Total debt | 25 | 729 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20192023
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20192023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20192023
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EJ Chief Executive Officer | Chief Executive Officer | 2007 |
AM Confidential Clerk | Confidential Clerk | 2019 |
| Former (4) | ||
MM Confidential Clerk | Confidential Clerk | 2014 – 2019 |
TL Deputy Member | Deputy Member | 2018 – 2021 |
JA Confidential Clerk | Confidential Clerk | 2014 – 2019 |
JA | Audit | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2018 | |
| Chairperson | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Oy Finntack Holding Ltd
Pharmacare Nova Oy Board members of Pharmacare Nova Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Minna Marike Kivelä | Confidential Clerk | 0 companies |
| Tapani Lyytikäinen | Deputy Member | 0 companies |
| Eero Johannes Nevanlinna | Chief Executive Officer | 0 companies |
| Ann-Marie Mirjam Viktoria Juttula | Confidential Clerk | 0 companies |
| Jari Antero Reinikainen | Confidential Clerk | 0 companies |
| Juho Aslak Johannes Himanen | Audit | 0 companies |
| Denis Pierre Marques | Board of Directors | 0 companies |
| Veikko Ensio Hytönen | Chairperson | 0 companies |